Company intelligence / Profile preview

Dolby Family Ventures

San Francisco, California, United Statesdolbyventures.com ↗

Ownership: Private
Development stage: Other

Overview

Dolby Family Ventures invests in early-stage (primarily pre-clinical, Phase 1, and some Phase 2) life science and precision neuroscience companies, backing diverse modalities and platforms targeting neurodegeneration, cognition, and disease-modifying therapeutics. Portfolio companies such as Vandria are entering Phase 1 for lead programs like VNA-318, targeting mitophagy for CNS and neurodegenerative indications.[1][2][4]

Therapeutic areas: RheumatologyPsychiatryGastroenterologyPulmonologyNeurology
Modalities: Small moleculeDeviceGene therapyRegenerative medicineComputational biologyBiologic
Industry: Investors

Partnerships

Hevolution Foundation (co-investor in Vandria)ND Capital (frequent syndicate partner)Lux Capital (frequent syndicate partner)Data Collective DCVC (frequent syndicate partner)

Beyond the preview

Go deeper on Dolby Family Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolby Family Ventures.